Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72226 - 72250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	PLA2G4A	5321	upregulated	Silicon Dioxide results in increased expression of PLA2G4A mRNA	1q31.1	A24207
Silicon dioxide	Approved	PLA2G4C	8605	upregulated	Silicon Dioxide analog results in increased expression of PLA2G4C mRNA	19q13.33	A24195
Silicon dioxide	Approved	PLA2G5	5322	upregulated	Silicon Dioxide analog results in increased expression of PLA2G5 mRNA	1p36.13	A24195
Silicon dioxide	Approved	PLA2R1	22925	downregulated	Silicon Dioxide analog results in decreased expression of PLA2R1 mRNA	2q23-q24	A24195
Silicon dioxide	Approved	PLAC8	51316	downregulated	Silicon Dioxide results in decreased expression of PLAC8 mRNA	4q21.22	A24196
Silicon dioxide	Approved	PLAG1	5324	upregulated	Silicon Dioxide analog results in increased expression of PLAG1 mRNA	8q12.1	A24195
Silicon dioxide	Approved	PLAT	5327	upregulated	Silicon Dioxide analog results in increased expression of PLAT mRNA	8p11.21	A24195
Silicon dioxide	Approved	PLAU	5328	upregulated	Silicon Dioxide analog results in increased expression of PLAU mRNA	10q22.2	A24195
Silicon dioxide	Approved	PLAU	5328	upregulated	Silicon Dioxide results in increased expression of PLAU mRNA	10q22.2	A24196
Silicon dioxide	Approved	PLAUR	5329	upregulated	Silicon Dioxide analog results in increased expression of PLAUR mRNA	19q13	A24195
Silicon dioxide	Approved	PLAUR	5329	upregulated	Silicon Dioxide results in increased expression of PLAUR mRNA	19q13	A24197 A24196
Silicon dioxide	Approved	PLCB1	23236	downregulated	Silicon Dioxide analog results in decreased expression of PLCB1 mRNA	20p12.3	A24195
Silicon dioxide	Approved	PLCD1	5333	downregulated	Silicon Dioxide analog results in decreased expression of PLCD1 mRNA	3p22.2	A24195
Silicon dioxide	Approved	PLCD4	84812	downregulated	Silicon Dioxide analog results in decreased expression of PLCD4 mRNA	2q35	A24195
Silicon dioxide	Approved	PLCG2	5336	upregulated	Silicon Dioxide analog results in increased expression of PLCG2 mRNA	16q24.1	A24195
Silicon dioxide	Approved	PLCH1	23007	downregulated	Silicon Dioxide analog results in decreased expression of PLCH1 mRNA	3q25.31	A24195
Silicon dioxide	Approved	PLCH2	9651	upregulated	Silicon Dioxide analog results in increased expression of PLCH2 mRNA	1p36.32	A24195
Silicon dioxide	Approved	PLCXD3	345557	downregulated	Silicon Dioxide analog results in decreased expression of PLCXD3 mRNA	5p13.1	A24195
Silicon dioxide	Approved	PLCXD3	345557	upregulated	Silicon Dioxide analog results in increased expression of PLCXD3 mRNA	5p13.1	A24194
Silicon dioxide	Approved	PLCZ1	89869	downregulated	Silicon Dioxide analog results in decreased expression of PLCZ1 mRNA	12p12.3	A24194
Silicon dioxide	Approved	PLD5	200150	downregulated	Silicon Dioxide analog results in decreased expression of PLD5 mRNA	1q43	A24195
Silicon dioxide	Approved	PLD6	201164	upregulated	Silicon Dioxide analog results in increased expression of PLD6 mRNA	17p11.2	A24195
Silicon dioxide	Approved	PLEK2	26499	upregulated	Silicon Dioxide analog results in increased expression of PLEK2 mRNA	14q23.3-q24.1	A24195
Silicon dioxide	Approved	PLEKHA4	57664	downregulated	Silicon Dioxide analog results in decreased expression of PLEKHA4 mRNA	19q13.33	A24195
Silicon dioxide	Approved	PLEKHA6	22874	downregulated	Silicon Dioxide analog results in decreased expression of PLEKHA6 mRNA	1q32.1	A24195

Displaying entries 72226 - 72250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability